Dr. John Hilton, MD
Claim this profileOttawa Hospital Research Institute
Studies Breast Cancer
Studies Tumors
13 reported clinical trials
34 drugs studied
Area of expertise
1Breast Cancer
Stage IV
PR negative
ER negative
2Tumors
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials John Hilton, MD is currently running
GSK5764227
for Advanced Cancer
The goal of this study is to assess the safety, tolerability, clinical activity and pharmacokinetics of GSK5764227. The study will also see how the levels of GSK5764227 will change over time at different dose amounts when administered alone and in combination with other medicines like carboplatin, cisplatin, atezolizumab, pembrolizumab, durvalumab, bevacizumab, cetuximab.
Recruiting1 award Phase 12 criteria
Targeted Cancer Drugs
for Cancer
Cancer drugs which target the effects of abnormal gene changes are called 'targeted therapies'. This study, called PM.1 or CAPTUR, will include some targeted therapies that are currently available. The purpose of this study is to find out what are the effects on a patient and their cancer when they are given a targeted therapy drug that is specific to an abnormal gene change in their cancer.
Recruiting1 award Phase 23 criteria
More about John Hilton, MD
Clinical Trial Related8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments John Hilton, MD has experience with
- CFI-400945
- Durvalumab
- Tucatinib
- CFI-402257
- Guideline-based Follow-up Care (standard Of Care)
- On-demand Personalized Follow-up Care
Breakdown of trials John Hilton, MD has run
Breast Cancer
Tumors
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Hilton, MD specialize in?
John Hilton, MD focuses on Breast Cancer and Tumors. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are PR negative.
Is John Hilton, MD currently recruiting for clinical trials?
Yes, John Hilton, MD is currently recruiting for 3 clinical trials in Ottawa Ontario. If you're interested in participating, you should apply.
Are there any treatments that John Hilton, MD has studied deeply?
Yes, John Hilton, MD has studied treatments such as CFI-400945, Durvalumab, Tucatinib.
What is the best way to schedule an appointment with John Hilton, MD?
Apply for one of the trials that John Hilton, MD is conducting.
What is the office address of John Hilton, MD?
The office of John Hilton, MD is located at: Ottawa Hospital Research Institute, Ottawa, Ontario K1H 8L6 Canada. This is the address for their practice at the Ottawa Hospital Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.